Ohio Willow Wood’s Appeal of IC Finding Goes Up In Smoke

iStock_000062460636_SmallOn February 19th, the Fed. Cir. affirmed a District Court’s finding of inequitable conduct in Ohio Willow Wood Co. (OWW) v. Alps South (Alps), LLC, following the Fed. Cir.’s remand of summary judgment of no inequitable conduct in 2013. (Ohio Willow Wood Cr. v. Alps South LLC, 2015 U.S. App LEXIS 2864 (Fed. Cir. 2016).) (A copy is available at the end of this post.)

The facts of the case are complex, and involve two reexaminations of U.S. Pat. No. 5,830,237, claiming a cushioning device for amputees, “SSGL.”

Continue reading

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , , | Leave a comment

Therasense Puts A World Of (Antitrust) Hurt On 3M

iStock_000000232341_SmallCommentators who have declared inequitable conduct dead and buried should study TransWeb, LLC v. 3M Innovative Properties Co., App. No. 2014-1646 (Fed. Cir., Feb. 10 2016). {A copy can be found at the end of this post.] The decision demonstrates how the “but-for materiality” and specific intent standards of the Therasense decision can open the door to Walker Process liability for antitrust violations and the award of trebled fees and damages.

In this case, 3M had sued TransWeb for patent infringement of several patents on non-woven, fluorinated fabrics used in respirator masks. The patents were invalidated due to 3M’s failure to disclose that it had obtained samples of the fabric from TransWeb, that had given away samples at a trade show more than a year prior to the effective filing date of the patents. There is a thorough analysis of the facts surrounding 3M’s obtention of the samples, but the Fed. Cir. found that the weight of the evidence corroborated the testimony of the TransWeb founder, that he had given out samples of the claimed product. This was enough to invalidate the 3M patents under the public use bar.

Continue reading

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , , , , | Leave a comment

Obama Launches Cancer Moonshot Task Force – But Where’s The Patent Power?

iStock_000035457638_SmallOn January 28, 2016, the White House issued a Memorandum establishing the Moonshot Task Force “to double the rate of progress in the fight against cancer – and put ourselves on a path to achieve in just 5 years research and treatment gains that otherwise might take a decade or more.” (A copy can be found at the end of this post.) The Task force, chaired by the VP, is to focus on “making the most of Federal Investments, targeted incentives, private sector efforts from industry and philanthropy, patient engagement initiatives, and other mechanisms to support cancer research and enable progress in treatment and care.” No mention of the importance of patent protection so far.

The membership will consist of the heads of 13 executive branch departments, agencies, and offices, including NIH, DOE, FDA, and NSF, among other. The head of the Department of Commerce is included, but the USPTO is not mentioned once.  However, I have been informed by the PTO Press Secretary that the USPTO, including Director Lee and Chief of Staff Aiyer attended the February 4th Task Force Meeting. The Task Force is to provide a report before the end of the year that includes seven recommendations, including to “identify and address any unnecessary regulatory barriers and consider ways to expedite administrative reforms.”

Continue reading

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , , | 2 Comments

Will Copyright Law Put Us on a Path to International Patent Exhaustion?

This is a guest post from Theresa Stadheim of Schwegman Lundberg & Woessner.

This article was first published by the American Intellectual Property Law (AIPLA) Patent Law Committee in its January 2016 newsletter.  For membership in AIPLA, visit here

Path through the woods

Will Copyright Law Put Us on a Path to International Patent Exhaustion? Lexmark v. Impression Products

Under the doctrine of patent exhaustion, once a patented product is sold in a sale authorized by the patent holder, patent rights in that product are exhausted.  Domestic patent exhaustion (i.e., patent exhaustion upon a domestic sale) is a common law doctrine in the United States, as well as being generally accepted worldwide.  However, the current Lexmark v. Impression Products litigation has raised the issue of whether international sales should also lead to exhaustion of patent rights.

The Lexmark v. Impression Products litigation

Lexmark manufactures printers and toner cartridges used in those printers.  In Lexmark Int’l, Inc. v. Ink Techs. Printer Supplies, LLC, plaintiff Lexmark alleged that it first sold the patented inkjet cartridges at issue outside of the United States, and that these cartridges were later acquired and remanufactured by defendants, including Impression Products, thereby infringing Lexmark’s patent.[i]

Continue reading

Posted in Miscellaneous, Uncategorized | Tagged , , , , , , , , | 1 Comment